What is the Difference Between PVC and PVDC in Pharmaceutical Blister Packaging?

Engineering Note: This technical documentation provides an in-depth material analysis of polyvinyl chloride (PVC) and polyvinylidene chloride (PVDC). It is designed to assist pharmaceutical packaging engineers in evaluating structural rigidity, thermoformability, and moisture/oxygen barrier properties for solid dosage blister applications.

When engineering pharmaceutical blister packaging, selecting the appropriate base web material is critical for balancing structural rigidity, formability, and barrier performance. Polyvinyl chloride (PVC) and polyvinylidene chloride (PVDC) represent the foundational and barrier-enhanced materials widely utilized across solid dosage packaging lines.

1. Polyvinyl Chloride (PVC) — The Formable Backbone

Polyvinyl chloride serves as the primary base material for thermoformed blister webs.

  • Key Advantages: PVC offers exceptional cost-effectiveness and superior thermoforming ease. Unplasticized (often referred to as Rigid PVC or RPVC) grades provide structural rigidity and physical protection for dosage forms while maintaining the flexibility required for a reliable push-through effect.
  • Dimensional Specifications: Typically manufactured at a thickness of 250μm (ranging from 200μm to 300μm depending on cavity geometry), standard PVC ensures cavities do not collapse under pressure.
  • Inherent Limitations: Uncoated PVC exhibits limited protection against environmental ingress, with a typical Water Vapor Transmission Rate (WVTR) of around 3.0 g/m²/day (at 38 °C/90% RH) and an Oxygen Transmission Rate (OTR) of approximately 20 mL/m²/day.
  • Compliance & Customization: PVC base webs can be pigmented or integrated with UV filters. Formulations are fully compliant with rigorous regulatory standards, including the European Pharmacopoeia (Ph. Eur. monograph 3.1.11), US Pharmacopoeia <661>, US 21 CFR, and relevant EU and Japanese food contact legislations.
2. Polyvinylidene Chloride (PVDC) — High-Barrier Enhancement

Because standard PVC lacks robust barrier properties, PVDC is coated onto the PVC substrate to dramatically increase resistance to moisture and oxygen. PVDC-coated films represent the most prevalent and economical barrier solution in pharmaceutical packaging.

  • Application & Structure: PVDC is applied via an aqueous emulsion coating process in multiple drying steps. It is categorized into duplex structures (e.g., PVC/PVDC ranging from 40gsm to 120gsm coating weights) and triplex structures (PVC/PE/PVDC), where an intermediate polyethylene (PE) layer is introduced to assist in deep-draw thermoforming applications.
  • Performance Grades:
    – Historic Grades: Provide medium-to-high barrier protection, significantly lowering WVTR (down to 0.25 g/m²/day) and OTR (down to 0.1 cc/m²/day).
    – Super Barrier Grades: Deliver more than double the barrier efficiency per gram of coating compared to historic grades, achieving ultra-low WVTR values ranging from 0.11 down to 0.06 g/m²/day in configurations up to 180gsm.
Summary of Differences
  • Role: PVC acts as the structural, thermoformable backbone of the blister package, whereas PVDC functions as a functional barrier coating applied on top of PVC.
  • Barrier Performance: While PVC alone offers minimal defense against moisture and oxygen, adding PVDC layers or super-barrier coatings transforms the material into a high-performance shield capable of protecting highly sensitive active pharmaceutical ingredients (APIs).